But yet the NWBO stock has gone NOWHERE since the release of the TLD data. NVCR has been very positive for it's shareholders since it's first Phase 3 GBM trial data was released. Even with the recent decline it is still been very lucrative if you were holding before the 1st Phase trial results were released. NWBO sure can't say that regardless of their exchange.
Market Data 
Markets 
AI
